Ceramides reduce CD36 cell surface expression and oxidised LDL uptake by monocytes and macrophages

Yingjun Luan, Helen R. Griffiths*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Oxidised LDL accumulates in macrophages following scavenger receptor (SR) uptake. The expression of the SR, CD36, is increased by oxidised LDL. The signalling molecule, ceramide, can modulate intracellular peroxides and increase lipid peroxidation. Ceramide also accumulates in atherosclerotic plaques. Thus, we have examined whether ceramide can modulate CD36 expression and function in human monocyte/macrophages. Addition of synthetic short chain ceramides or the action of sphingomyelinase to generate physiological long chain ceramides in situ caused significant reductions in CD36 expression by monocytes/macrophages which was not due to inhibition of mRNA expression. Inhibition of proteasomal degradation using lactacystin had no effect on CD36 expression, however, flow cytometric analysis of permeabilised cells suggested an intracellular trafficking blockade. Ceramide treated monocytes/macrophages showed dose dependent reduction in oxidised LDL uptake. Taken together, it is suggested that ceramide blocks the transport of CD36 to the membrane of monocytes/macrophages, thereby preventing uptake of oxidised LDL. © 2006 Elsevier Inc. All rights reserved.

Original languageEnglish
Pages (from-to)89-99
Number of pages11
JournalArchives of Biochemistry and Biophysics
Issue number1
Publication statusPublished - Jun 2006


  • C-ceramide
  • CD36
  • macrophage
  • monocyte
  • oxidised LDL
  • sphingomyelinase


Dive into the research topics of 'Ceramides reduce CD36 cell surface expression and oxidised LDL uptake by monocytes and macrophages'. Together they form a unique fingerprint.

Cite this